Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean 2019 90 2?
Displaying drugs 7976 - 8000 of 11693 in total

Acetylcysteine zidrimer

Investigational

Daidzin

Experimental
Matched Iupac: … 3-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen- …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Imazaquin

Experimental
Matched Iupac: … 2-[(4R)-4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Atl146e

ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors.
Investigational
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Lixivaptan

Investigational
Matched Iupac: … chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2- …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Robenacoxib

Robenacoxib is a non-steroidal anti-inflammatory drug used in veterinary medicine for the relief of pain and inflammation in cats and dogs.
Experimental
Vet approved
Matched Iupac: … 2-{5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid …
Matched Categories: … Selective Cyclooxygenase 2 Inhibitors (NSAIDs) …

PF-00610355

PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Investigational
Matched Iupac: … 2-[3-(2-{[(2R)-2-hydroxy-2-(4-hydroxy-3-methanesulfonamidophenyl)ethyl]amino}-2-methylpropyl)phenyl]- …
Matched Categories: … Adrenergic beta-2 Receptor Agonists …

Ilaprazole

Ilaprazole has been investigated in Helicobacter Infections.
Investigational
Matched Iupac: … 2-[(4-methoxy-3-methylpyridin-2-yl)methanesulfinyl]-5-(1H-pyrrol-1-yl)-1H-1,3-benzodiazole …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Mebhydrolin

Experimental
Matched Iupac: … 5-benzyl-2-methyl-1H,2H,3H,4H,5H-pyrido[4,3-b]indole …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

LY2828360

LY2828360 is under investigation in clinical trial NCT01319929 (A Study of LY2828360 in Patients With Osteoarthritic Knee Pain).
Investigational
Matched Iupac: … 8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)-9H-purine …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol

Experimental

(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate

Experimental
Matched Iupac: … (2R)-3,3-dimethylbutan-2-yl methylphosphinate …

Ncs-Chromophore

Experimental
Matched Iupac: … -2-oxo-1,3-dioxolan-4-yl]-5-oxatricyclo[8.3.0.0^{4,6}]trideca-1(13),9-dien-2,7-diyn-12-yl 2-hydroxy-7 ... (4S,6R,9E,11R,12R)-11-{[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-methyl-3-(methylamino)oxan-2-yl]oxy}-4-[(4R) …

PVX-410 component CD138 260-268(GLVGLIFAV)

Investigational

D-tartaric acid

Experimental

Aficamten

Investigational

Solasodine

Investigational

Prostaglandin B2

Experimental
Matched Iupac: … (5Z)-7-{2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoic acid …

LY2181308

LY2181308 is investigated in clinical trials for treating solid tumors. LY2181308 is a solid. LY2181308 is directed against a molecular target called survivin. LY2181308 is known to target baculoviral IAP repeat-containing protein 5. LY2181308 is an anti-sense oligonucleotide that potently downregulated survivin expression in human cancer cells derived from lung,...
Investigational

LY2275796

LY2275796 is a second-generation antisense anti-cancer drug candidate for clinical development. LY2275796 targets eukaryotic initiation factor- 4E (eIF-4E), a protein involved in the translation of key growth and survival factors that drive tumor progression, angiogenesis and metastases.
Investigational

BDBM249432

Investigational

Benzquinamide

Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
Withdrawn
Matched Iupac: … 3-(diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

5,7-Dichlorokynurenic acid

Experimental
Matched Iupac: … 5,7-dichloro-4-hydroxyquinoline-2-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Varespladib methyl

Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Investigational
Matched Iupac: … methyl 2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetate …
Matched Categories: … Heterocyclic Compounds, 2-Ring …

Carbazochrome

Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Displaying drugs 7976 - 8000 of 11693 in total